You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed hematologic malignancy

Showing 51 - 75 of 8,407
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed or Refractory B-cell Hematologic Malignancies Trial in Beijing, Nanjing (HEC89736)

Active, not recruiting
  • Relapsed or Refractory B-cell Hematologic Malignancies
  • Beijing, Beijing, China
  • +1 more
May 5, 2022

Adult Relapsed/Refractory B-cell Hematologic Malignancies Trial in Beijing (CD19-CAR-NK)

Recruiting
  • Adult Relapsed/Refractory B-cell Hematologic Malignancies
  • CD19-CAR-NK
  • Beijing, Beijing, China
    The Fifth Medical Center of Chinese People's Liberation Army (PL
Dec 1, 2022

Relapsed or Refractory Hematologic Malignancies Trial in Chicago (Omacetaxine, Venetoclax)

Recruiting
  • Relapsed or Refractory Hematologic Malignancies
  • Chicago, Illinois
    University of Illinois Cancer Center
Sep 27, 2022

Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical

Recruiting
  • Hematologic Malignancy
  • Fludarabine
  • Atlanta, Georgia
    Caitlin Guzowski
Sep 1, 2022

Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Total Lymphoid Irradiation
  • +10 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 28, 2022

Relapsed or Refractory Multiple Myeloma, Hematological Malignancy Trial in Maroochydore, Tugun, Frankston (SG301)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Hematological Malignancy
  • Maroochydore, Queensland, Australia
  • +2 more
Dec 21, 2020

Multiple Myeloma, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in United States (PRT1419)

Completed
  • Multiple Myeloma
  • +3 more
  • Denver, Colorado
  • +4 more
Nov 14, 2022

Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)

Recruiting
  • Hematologic Malignancy
  • +4 more
  • Palliative Care
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 24, 2023

Hematologic Malignancy Trial (Cyclophosphamid, ATG)

Not yet recruiting
  • Hematologic Malignancy
  • (no location specified)
Oct 29, 2023

Hematologic Malignancy Trial in Copenhagen (HM-PRO)

Active, not recruiting
  • Hematologic Malignancy
  • HM-PRO
  • Copenhagen, Denmark
    Dept. of Hematology
Jun 14, 2022

Immune Profiling for Cancer Immunotherapy Response

Recruiting
  • Cancer
  • +3 more
  • Methylation Cytometry
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Nov 6, 2023

Hematological Malignancies Trial in Guangzhou, Tianjin (Nemtabrutinib)

Recruiting
  • Hematological Malignancies
  • Guangzhou, Guangdong, China
  • +2 more
Aug 10, 2022

Venetoclax Tablets Crushed and Dissolved Into a Solution

Not yet recruiting
  • Hematologic Malignancy
  • +18 more
  • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Nov 8, 2023

Tumors, Hematologic Tumors, Tumors by Site Trial in Wuhan (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +3 more
  • RD13-02 cell infusion
  • Wuhan, Hubei, China
    Union Hospital, Huazhong University of Science and Technology
Jun 8, 2023

Cognitive Aftereffects of Neurotoxicity in Children and Young

Not yet recruiting
  • Lymphoma
  • Leukemia
    • Los Angeles, California
    • +2 more
    Feb 2, 2023

    Patient Fitness and Body Composition During Hematopoietic Stem

    Active, not recruiting
    • Hematologic Malignancy
    • Observational
    • Seattle, Washington
      VA Puget Sound Health Care System
    Aug 2, 2022

    Relapsed and/or Refractory Acute Myeloid Leukemia, High Risk Hematologic Malignancies Trial in Langfang (anti-CD33 CAR T cells)

    Not yet recruiting
    • Relapsed and/or Refractory Acute Myeloid Leukemia
    • High Risk Hematologic Malignancies
    • anti-CD33 CAR T cells
    • Langfang, Hebei, China
      Hebei Yanda Lu Daopei Hospital
    Jun 30, 2022

    Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)

    Recruiting
    • Solid Tumor Malignancy
    • +4 more
    • mRNA-1273
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 14, 2023

    Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (allogenic CD19-CAR-NK cells)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • allogenic CD19-CAR-NK cells
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 11, 2023

    NHL, Multiple Myeloma, Blood Cancer Trial in Minneapolis, Houston, Fairfax (IDP-023, Rituximab, Daratumumab)

    Recruiting
    • NHL
    • +6 more
    • Minneapolis, Minnesota
    • +2 more
    Nov 7, 2023

    Relapsed/Refractory, High Risk Hematologic Malignancies, T-ALL/Lymphoma Trial in Langfang (CD7CAR T cells)

    Recruiting
    • Relapsed/Refractory, High Risk Hematologic Malignancies
    • T-ALL/Lymphoma
    • CD7CAR T cells
    • Langfang, Hebei, China
      Hebei Yanda Lu Daopei Hospital
    Jun 30, 2022

    Transplant-Related Hematologic Malignancy Trial in Atlanta (Sargramostim, Control Arm)

    Recruiting
    • Transplant-Related Hematologic Malignancy
    • Atlanta, Georgia
      Northside Hospital
    Oct 19, 2022

    Multiple Myeloma (MM), DLBCL, Not Otherwise Specified, Double Hit Lymphoma Trial in Spain (IDP-121)

    Recruiting
    • Multiple Myeloma (MM)
    • +5 more
    • Santander, Cantabria, Spain
    • +4 more
    Jun 19, 2023

    Hematologic Malignancy, Lymphoma Trial (Home-based training, Center-based training)

    Not yet recruiting
    • Hematologic Malignancy
    • Lymphoma
    • Home-based training
    • Center-based training
    • (no location specified)
    Mar 20, 2023

    Pediatric Patients, Hematologic Malignancy, Other Hematologic Condition Trial in Aurora (CliniMACS Plus Instrument)

    Not yet recruiting
    • Pediatric Patients
    • +2 more
    • CliniMACS Plus Instrument
    • Aurora, Colorado
      Children's Hospital Colorado
    Jun 29, 2022